Formula Growth’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$831K Hold
25,824
0.37% 95
2025
Q4
$930K Hold
25,824
0.36% 99
2025
Q3
$813K Hold
25,824
0.29% 103
2025
Q2
$1.1M Hold
25,824
0.42% 95
2025
Q1
$1.15M Sell
25,824
-1,000
-4% -$53.8K 0.47% 82
2024
Q4
$1.47M Hold
26,824
0.5% 75
2024
Q3
$1.13M Sell
26,824
-17,876
-40% -$851K 0.39% 89
2024
Q2
$2.05M Buy
44,700
+1,720
+4% +$81.1K 0.75% 54
2024
Q1
$2.24M Buy
+42,980
New +$1.88M 0.71% 57
2020
Q3
Sell
-45,000
Closed -$622K 168
2020
Q2
$622K Hold
45,000
0.11% 131
2020
Q1
$413K Hold
45,000
0.08% 128
2019
Q4
$783K Hold
45,000
0.1% 128
2019
Q3
$681K Buy
+45,000
New +$787K 0.1% 136

Other funds holding VCEL

Formula Growth's VCEL Position: Q1 2026 in Review

Formula Growth held its Vericel Corp (VCEL) position steady in Q1 2026 at 25,824 shares worth $831K. The position accounts for 0.37% of the portfolio, ranked #95.

Formula Growth first reported a position in VCEL in Q3 2019 and has held it in 13 quarters since. The position peaked at $2.24M in Q1 2024. 279 funds tracked by Wall St. Rank hold VCEL as of Q1 2026.

  • Formula Growth held 25,824 shares of Vericel Corp worth $831K as of Q1 2026.
  • Formula Growth left its Vericel Corp share count unchanged in Q1 2026.
  • Vericel Corp made up 0.37% of Formula Growth's portfolio in Q1 2026, its #95 holding.
  • Formula Growth first reported a position in Vericel Corp in Q3 2019 and has held it in 13 quarters since.
  • Formula Growth's Vericel Corp position peaked at $2.24M in Q1 2024.
  • 279 funds tracked by Wall St. Rank held Vericel Corp as of Q1 2026.

Based on Formula Growth's 13F filing for Q1 2026, filed 14 May 2026.